110 results match your criteria Laser Treatment of Benign Pigmented Lesions


Clinical Evaluation of Safety and Efficacy of a 670-nm Picosecond Laser for Treatment of Benign Pigmented Lesions in Asians.

Dermatol Surg 2021 May;47(5):e153-e158

All authors are affiliated with the Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. K.E.R. Evangelista is currently affiliated with the Department of Dermatology, Research Institute for Tropical Medicine, Manila, Philippines.

Background: Picosecond lasers are increasingly being investigated in treating pigmentation disorders because they may provide better treatment efficacy and comfort compared with nanosecond lasers.

Objective: This study aims to evaluate the efficacy and side effect of a novel 670-nm picosecond laser in the removal of benign pigmented lesions (BPLs) in individuals with Fitzpatrick skin types (FST) III and IV.

Materials And Methods: Fifteen subjects with solar lentigines and 7 subjects with ABNOMs received a single treatment with a 670-nm picosecond laser. Read More

View Article and Full-Text PDF

Asymptomatic disseminated telangiectasias: a rare case of cutaneous collagenous vasculopathy.

Dermatol Online J 2020 Oct 15;26(10). Epub 2020 Oct 15.

Department of Dermatology, Mater Hospital Brisbane, Queensland.

Cutaneous collagenous vasculopathy (CCV) is a rare idiopathic microangiopathy affecting superficial dermal blood vessels. It is characterized by asymptomatic, disseminated, telangiectatic macules that typically involve the extremities. We report the case of a 58-year-old woman who presented with widespread telangiectasias of three years' duration on the upper extremities and abdomen. Read More

View Article and Full-Text PDF
October 2020

[Treatment of nevus of Ota and Ito and epidermal nevus syndrome].

Hautarzt 2020 Dec;71(12):926-931

National Institute of Laser Enhanced Sciences (NILES), Cairo University, Giza, Ägypten.

Nevus of Ota, nevus of Ito and nevus of Hori are special melanocytic nevi that have a slate-brown or blue/grey coloring. They are pigmented disorders characterized by its heterotopic melanocytic dermal location and by blue/brown unilateral and sometimes bilateral facial patch in case of nevus of Ota, and in the supraclavicular, scapular, and deltoid region in case of nevus of Ito. It is more common in patients with Asian and dark-skinned ethnic backgrounds. Read More

View Article and Full-Text PDF
December 2020

Safety and Efficacy of a Novel 730 nm Picosecond Titanium Sapphire Laser for the Treatment of Benign Pigmented Lesions.

Lasers Surg Med 2021 Apr 1;53(4):429-434. Epub 2020 Sep 1.

Cosmetic Laser Dermatology, 9339 Genesee Avenue, Suite 300, San Diego, 92121, California.

Background And Objectives: Picosecond lasers in dermatology were originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have expanded its clinical indications to include treatment of benign pigmented lesions, photodamage, melasma, and scar revision. In this retrospective review, we evaluate a novel 730 nm picosecond titanium sapphire laser in treating benign pigmented lesions. Read More

View Article and Full-Text PDF

A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.

Lasers Surg Med 2021 01 31;53(1):95-103. Epub 2020 Aug 31.

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Background And Objectives: Treatment of melasma with lasers remains a challenge due to its limited clinical efficacy in addition to high rates of recurrence and side effects. Recently, picosecond lasers have shown favorable results in treatment of benign pigmented lesions. To compare the efficacy and safety of using a 755-nm picosecond laser for the treatment of melasma in a split-face manner, having one side treated with a fractionated beam (diffractive lens array [DLA] coupling) and with a full-beam (flat optics) on the other side. Read More

View Article and Full-Text PDF
January 2021

A New 675 nm Laser Device in the Treatment of Melasma: Results of a Prospective Observational Study.

Photobiomodul Photomed Laser Surg 2020 Sep 21;38(9):560-564. Epub 2020 Aug 21.

Unit of Dermatology, University of Rome, Tor Vergata, Rome, Italy.

This study evaluates the efficacy and safety of a new 675 nm laser source system on melasma. Melasma is an acquired circumscribed hyperpigmented disorder that has a negative impact on patients' life quality. Different treatments are currently available. Read More

View Article and Full-Text PDF
September 2020

A Unique Presentation of Gingival Melanoacanthoma: Case Report and Review of Literature.

Cureus 2020 Mar 18;12(3):e7315. Epub 2020 Mar 18.

Periodontics, Maulana Azad Institute of Dental Sciences, New Delhi, IND.

Melanoacanthoma is a benign, deeply pigmented condition of the oral mucosa characterized by the proliferation of melanocytes and keratinocytes. A 60-year-old male, with no history of systemic diseases or medical treatment, presented with an asymptomatic diffuse pigmentation involving the maxillary and mandibular gingiva. The histopathology of the anomalous pigmented area was analyzed and the dendritic melanocytes expressed positively for Masson-Fontana, S-100, and HMB-45. Read More

View Article and Full-Text PDF

A Systematic Review of Picosecond Laser in Dermatology: Evidence and Recommendations.

Lasers Surg Med 2021 01 13;53(1):9-49. Epub 2020 Apr 13.

Wellman Center for Photomedicine, Massachusetts General Hospital, 50 Blossom Street, Boston, Massachusetts, 02114.

Background And Objectives: The use of picosecond laser in dermatology was originally focused on optimizing the removal of unwanted tattoos. Subsequent advances in this technology have broadened its clinical indications to include treatment of benign pigmented lesions, photodamage, melasma, and scar revision. In this systematic review, evidence-based recommendations are developed for the use of picosecond laser in dermatology. Read More

View Article and Full-Text PDF
January 2021

Recent advances in managing and understanding seborrheic keratosis.

Authors:
Uwe Wollina

F1000Res 2019 28;8. Epub 2019 Aug 28.

Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, 01067, Germany.

Seborrheic keratosis (SK) is a common benign epidermal tumor with predominance in adult patients. Whereas common SKs are more frequent in Caucasians, dermatosis papulosa nigra is more prevalent in patients with a Fitzpatrick skin type of at least 3. There seems to be a link between extrinsic skin aging and the occurrence of SK. Read More

View Article and Full-Text PDF

Evolution of the Picosecond Laser: A Review of Literature.

Dermatol Surg 2019 02;45(2):183-194

Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.

Background: Picosecond pulse duration lasers (PS) have altered the field of dermatology. PS were initially used in tattoo removal, to optimize efficacy and reduce side effects with nanosecond domain lasers. More recently, they have been demonstrated to be effective in the treatment of pigmentary disorders, acne scarring, and photoaging. Read More

View Article and Full-Text PDF
February 2019

Treatment of benign pigmented lesions using a novel Dermal Cooling System.

Lasers Surg Med 2019 01 27;51(1):59-61. Epub 2018 Nov 27.

Department of Dermatology, University of California San Diego, La Jolla 92122, California.

Benign pigmented lesions are among the most common dermatologic diagnoses that patients seek treatments for. Treatment modalities range from cryotherapy to light and laser-based technologies. These treatments have been shown to be effective, yet may lead to dyschromia or significant downtime. Read More

View Article and Full-Text PDF
January 2019

Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.

Lasers Surg Med 2019 01 25;51(1):14-22. Epub 2018 Oct 25.

Division of Dermatology, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Background And Objectives: Cutaneous pigmentary disorders are both more common and more difficult to treat in patients with skin color given the higher melanin content in the epidermis. Although Q-switched lasers are widely considered to be the standard treatment for both epidermal and dermal pigmentary conditions, a very high risk of post-inflammatory hyperpigmentation (PIH) of up to 25% is seen in patients with skin of color. Recently, the novel picosecond laser with pulse durations operating at sub-nanosecond domains has been shown to be effective in tattoo removal and in the treatment of acne scars. Read More

View Article and Full-Text PDF
January 2019

Long pulsed dye laser with a back-to-back double-pulse technique and compression for the treatment of epidermal pigmented lesions.

Lasers Surg Med 2019 02 15;51(2):136-140. Epub 2018 Oct 15.

Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 1600, Chicago 60611, Illinois.

Background: In the recent past, long pulsed dye lasers (LPDL) have been investigated for the treatment of epidermal pigmented lesions (EPLs). Using a pigmented lesion compression headpiece, blood is pushed laterally out of the laser field focusing laser energy on melanin. Recent studies have demonstrated excellent responses using a single-pulse at the following settings: 9-12 J/cm , 1. Read More

View Article and Full-Text PDF
February 2019

Therapeutic strategies for pigmented purpuric dermatoses: a systematic literature review.

J Dermatolog Treat 2019 Mar 18;30(2):105-109. Epub 2018 May 18.

a Department of Dermatology , University of Patras, University General Hospital of Patras , Rio , Greece.

Background: Pigmented purpuric dermatoses (PPDs) is a group of diseases with distinguishing clinical characteristics, characterized mainly by purpuric skin lesions. The course of PPDs is chronic and recurrences are common. Although PPDs are considered to be benign, the associated symptoms, such as pruritus, and their cosmetic effect can be extremely distressing to patients. Read More

View Article and Full-Text PDF

Picosecond Laser Treatment for Tattoos and Benign Cutaneous Pigmented Lesions (Secondary publication).

Authors:
Kenichiro Kasai

Laser Ther 2017 Dec;26(4):274-281

Kasai Clinic for Plastic Surgery.

Background And Aims: The selective removal of tattoos and benign cutaneous pigmented lesions with laser energy evolved rapidly with the development of the nanosecond-domain Q-switched laser (ns-laser). Recently, however, a series of picosecond-domain lasers (ps-lasers) with pulsewidths less than 1 ns has become commercially available, enabling more efficient and faster removal of pigmented lesions in the field of dermatologic laser surgery.

Rationale Behind The Ps-laser: The efficacy of the ns-laser depended on the theory of selective photothermolysis, whereby an extremely short pulse width was delivered less than the thermal relaxation time (TRT) of a target. Read More

View Article and Full-Text PDF
December 2017

Recurrence of melanocytic lesions after laser treatment: benign vs. malignant upon dermoscopy.

J Eur Acad Dermatol Venereol 2017 Dec 16;31(12):e526-e528. Epub 2017 Aug 16.

Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.

View Article and Full-Text PDF
December 2017

Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.

Lasers Surg Med 2017 11 29;49(9):819-826. Epub 2017 May 29.

Memorial Sloan Kettering Cancer Center, Dermatology Service, 16 E. 60th Street, 4th Floor Dermatology, New York, New York, 10022.

Introduction: Lentigo maligna (LM) is melanoma in situ on sun-damaged skin and presents diagnostic challenges due to overlapping features with benign pigmented lesions. Cosmetic treatments may be inadvertently performed on LM. The aim of this study is to estimate the prevalence of LM with prior cosmetic treatment, and evaluate surgical outcomes. Read More

View Article and Full-Text PDF
November 2017

Medium-sized nevus spilus of the neck treated with pulsed dye laser.

Dermatol Ther 2017 Jul 20;30(4). Epub 2017 Apr 20.

Abrusci Studio, Milan, Italy.

Patients with large benign melanocytic lesions located on the neck represent a therapeutic challenge since the neck is a high-risk area for hypertrophic scarring and/or retraction. When treating a benign, extensive and visible melanocytic lesion, the choice of therapy mainly depends on the likelihood of improved cosmesis. We report a case of a 33-year-old woman with a medium-sized Nevus Spilus located on the neck, successfully treated with four sessions of pulsed dye laser. Read More

View Article and Full-Text PDF

Argon Laser Photoablation for Treating Benign Pigmented Conjunctival Nevi.

Middle East Afr J Ophthalmol 2016 Jul-Sep;23(3):247-9

Department of Research, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Purpose: To evaluate the outcomes of argon laser photoablation of benign conjunctival pigmented nevi with different clinical presentations.

Patients And Methods: This interventional case series was conducted between July 2014 and January 2015. Patients presenting with benign conjunctival nevi were included. Read More

View Article and Full-Text PDF

Melanoma diagnosed in lesions previously treated by laser therapy.

J Dermatol 2017 Jan 27;44(1):23-28. Epub 2016 Jun 27.

Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.

Laser therapy has become a routine procedure in dermatological practice and is frequently also used for pigmented lesions. Few reports exist of melanomas diagnosed in lesions previously treated by laser therapy. Between 2007 and 2014, we identified 11 patients who presented to our department with a melanoma diagnosed in a region previously treated by laser therapy. Read More

View Article and Full-Text PDF
January 2017

Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians.

Lasers Surg Med 2016 Apr 12;48(4):354-9. Epub 2016 Jan 12.

Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Background/objective: Solar lentigines are benign pigmented lesions that occur mostly on sun-exposed areas. Q-switched and ablative lasers are effective for removing these lesions but the high incidence of postinflammatory hyperpigmentation raises concern in darker skin types. The objective of this study is to compare the efficacy and degree of postinflammatory hyperpigmentation with the Q-switched Nd:YAG and fractional carbon dioxide (CO2 ) laser for treatment of solar lentigines in Asians. Read More

View Article and Full-Text PDF

Carbon dioxide laser ablation of dermatosis papulosa nigra: high satisfaction and few complications in patients with pigmented skin.

Lasers Med Sci 2016 Apr 11;31(3):593-5. Epub 2016 Feb 11.

Laser Unit, Dermatology Centre, Salford Royal NHS Foundation Trust, Stott Lane, Manchester, M6 8HD, UK.

Dermatosis papulosa nigra (DPN) is a common condition of pigmented skin. Whilst lesions are benign, they may be symptomatic or cosmetically disfiguring. Ablative lasers have previously been reported as a useful therapeutic modality in DPN. Read More

View Article and Full-Text PDF

A retrospective analysis on the management of pigmented lesions using a picosecond 755-nm alexandrite laser in Asians.

Lasers Surg Med 2016 Jan 22;48(1):23-9. Epub 2015 Dec 22.

Division of Dermatology, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Background And Objectives: Photo-aging in Chinese often presents with benign pigmentary lesions. Q-switched lasers for pigmentary lesions in Asians had reported a risk of post-inflammatory hyperpigmentation (PIH) up to 25%. Longer pulse widths in the millisecond domains were advocated with reduced risk of PIH. Read More

View Article and Full-Text PDF
January 2016

Laser applications for benign oral lesions.

Lasers Surg Med 2015 Oct 26;47(8):643-50. Epub 2015 Aug 26.

Carolyn and Peter Lynch Center for Laser and Reconstructive Surgery, Division of Facial Plastic and Reconstructive Surgery, Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, 02114.

Background And Objective: Different subspecialists treat benign intraoral lesions using various approaches including surgical excision, medical therapy, sclerotherapy, and laser photocoagulation. The goal of this study was to establish whether lasers could effectively target and destroy oral lesions containing endogenous chromophores, while minimizing injury to unaffected adjacent tissues and critical structures.

Materials And Methods: This retrospective study involved 26 cases of benign oral lesions, both vascular and pigmented, which were addressed by means of selective laser treatment. Read More

View Article and Full-Text PDF
October 2015

Laser treatment of periocular skin conditions.

Clin Dermatol 2015 Mar-Apr;33(2):197-206

Department of Dermatology, University of Connecticut Health Center, 21 South Road, Farmington, Connecticut. Electronic address:

Advances in laser technology in recent decades have increased the options for the treatment of dermatologic conditions of the eye and eyelid. Benign tumors can be laser-ablated with relative ease, and vascular and melanocytic lesions can be precisely targeted with modern lasers. In this contribution, we review treatment of periocular pigmented lesions, including melanocytic nevi and nevus of Ota; vascular lesions including telangiectasias, port wine stains, and infantile hemangiomas; hair removal; eyeliner tattoo removal; laser ablation of common benign periocular tumors, such as syringomas, xanthelasma, milia, and seborrheic keratoses; and laser resurfacing. Read More

View Article and Full-Text PDF
December 2015

Lasers for nevi: a review.

Lasers Med Sci 2015 Sep 16;30(7):1991-2001. Epub 2014 Dec 16.

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1475 NW 12th AVE, Miami, FL, 33136, USA,

A nevus is described as a benign, often pigmented, skin growth that can be congenital or acquired. Different types of nevi are located at different depths within the skin. Traditional treatments for nevi include topical treatments, dermabrasion, and excision, which are generally ineffective, invasive, and often result in scars and dyspigmentation. Read More

View Article and Full-Text PDF
September 2015

Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature.

Authors:
S Ud-Din A Bayat

Br J Dermatol 2013 Oct;169 Suppl 3:71-81

Plastic and Reconstructive Surgery Research, Bayat Research Group, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, U.K; University Hospital of South Manchester NHS Foundation Trust, Institute of Inflammation and Repair, Dermatology Group, Faculty of Medical and Human Sciences, University of Manchester,  Manchester Academic Health Science Centre, Manchester, M23 9LT, U.K.

Keloid disease (KD) is a common, benign, dermal fibroproliferative growth of unknown aetiology. Lesions tend to grow over time; they often recur following therapy and do not regress spontaneously. KD causes considerable discomfort due to pain, pruritus and inflammation, and a significant psychosocial impact with reduced quality of life. Read More

View Article and Full-Text PDF
October 2013

Divided or kissing nevus of the penis.

Dermatol Online J 2013 Oct 16;19(10):20027. Epub 2013 Oct 16.

Fort Belvoir Community Hospital.

The divided or kissing nevus is an unusual congenital melanocytic nevus. By definition, these nevi appear on skin that separates during embryological development. These lesions have been reported on the eyelids, fingers, and rarely the penis. Read More

View Article and Full-Text PDF
October 2013